Here are Jim Cramer's quick takeaways on 6 stocks in Friday's news
Clorox: The consumer products giant saw a huge increase in profits. It is also recovering from last year's cyberattack. “Things…
health care industry
Bristol Myers Squibb (BMY) Q4 2023 Earnings Report
Bristol-Myers Squibb reported quarterly earnings and revenue on Friday that beat expectations as its portfolio of new drugs posted strong…
This little-known oncology stock could rise more than 70%, says Citi
Olema Oncology could be a leading player in developing therapies for women's cancer, particularly breast cancer, according to Citi Research.…
Symptoms of Excessive Screen Time Cost US $73 Billion a Year: Study
American workers spend too much time looking at screens. More than 104 million people in the U.S., including nearly 70%…
Pfizer (PFE) 2023 Fourth Quarter Earnings Report
Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit as the company's declining Covid business performed better than expected. The…
Elon Musk's Neuralink implants brain technology in a human patient for the first time
Jonathan Raa | Nurfoto | fake images Elon Musk's neurotech startup Neuralink implanted its device in a human for the…
Merck and J&J CEOs agree to testify at Senate hearing on drug prices
U.S. Senator Bernie Sanders, independent from Vermont, speaks during a People's Action rally, protesting pharmaceutical companies' lobbying against allowing Medicare…
Humana reports grim forecast for 2024 due to rising medical costs
Signs are displayed at a Humana Inc. office building in Louisville, Kentucky, U.S., Sunday, February 3, 2019. Humana is scheduled…
Analysts Love These Biotech Stocks, Giving 4 an Over 100% Lead
The healthcare sector may have done poorly in recent years, but analysts are optimistic about it at the moment. “Just…
Zepbound is off to a good start, but here's what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly's recently launched weight-loss drug Zepbound. Investors will tune into the company's fourth-quarter earnings conference…